"The trial achieved its primary endpoint by demonstrating a statistically significant and superior reduction in kidney disease progression, major adverse cardiovascular events and death of 24% for people treated with semaglutide 1.0 mg compared to placebo," Novo said in a statement on Tuesday
We have other supportive modalities to assist you in your weight loss: NAD+, our probiotic which helps with insulin resistance and aids in digestion, and nausea medication if needed
However, semaglutide has dedicated cardiovascular outcome data from the SELECT trial showing a 20% reduction in major adverse cardiac events
This guide explores everything about semaglutide-related fatigue: why it happens, when to expect it, how to distinguish normal adjustment fatigue from concerning tiredness, and most importantly, proven strategies to maintain your energy levels throughout treatment
Additional Supporting Research Metabolic Adaptations During Weight Loss Kim, J
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity